Related Experiment Videos

Optimum dosing of ipilimumab in melanoma: too little, too late?

Alexander M Menzies1, Georgina V Long1

  • 1Melanoma Institute Australia, Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, NSW, Australia.

The Lancet. Oncology
|April 1, 2017
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos